EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, MCET: Multicell Technologies Inc

26 Dec 2025
LAST:

0.0005

CHANGE:
 0.00		OPEN:
0.0005		HIGH:
0.0005		ASK:
0.0000		VOLUME:
100
CHG(%):
0.00		PREV:
0.0001		LOW:
0.0005		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume

PROFILE

Name:Multicell Technologies Inc
About:MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers; and MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of various cancers. The company also develops Ideal BioStent, a bioabsorbable stent for interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. has a license agreement with Corning Incorporated and Pfizer Inc. The company was formerly known as Exten Industries, Inc. and changed its name to MultiCell Technologies, Inc. in April 2004. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island.
Sector:Healthcare
Industry:Biotechnology
Address:68 Cumberland Street, Woonsocket, RI, United States, 02895
Website:www.multicelltech.com
CUSIP:62544S200
CIK:0000811779
ISIN:US62544S2005
FIGI:BBG000DJQRP8

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download